vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.
Palomar Holdings, Inc. is the larger business by last-quarter revenue ($253.4M vs $151.7M, roughly 1.7× Nutex Health, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs -41.1%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 46.2%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
NUTX vs PLMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $253.4M |
| Net Profit | $11.8M | — |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 28.7% |
| Net Margin | 7.8% | — |
| Revenue YoY | -41.1% | 62.7% |
| Net Profit YoY | -80.8% | — |
| EPS (diluted) | $2.34 | $2.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $253.4M | ||
| Q3 25 | $267.8M | $244.7M | ||
| Q2 25 | $244.0M | $203.3M | ||
| Q1 25 | $211.8M | $174.6M | ||
| Q4 24 | $257.6M | $155.8M | ||
| Q3 24 | $78.8M | $148.5M | ||
| Q2 24 | $76.1M | $131.1M | ||
| Q1 24 | $67.5M | $118.5M |
| Q4 25 | $11.8M | — | ||
| Q3 25 | $55.4M | $51.5M | ||
| Q2 25 | $-17.7M | $46.5M | ||
| Q1 25 | $21.2M | $42.9M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | $30.5M | ||
| Q2 24 | $-364.0K | $25.7M | ||
| Q1 24 | $-364.0K | $26.4M |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | 28.7% | ||
| Q3 25 | 48.7% | 27.4% | ||
| Q2 25 | 13.8% | 29.5% | ||
| Q1 25 | 38.1% | 30.8% | ||
| Q4 24 | 44.4% | 28.9% | ||
| Q3 24 | 12.3% | 25.9% | ||
| Q2 24 | 7.0% | 25.5% | ||
| Q1 24 | 2.1% | 29.0% |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 20.7% | 21.0% | ||
| Q2 25 | -7.3% | 22.9% | ||
| Q1 25 | 10.0% | 24.6% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | 20.5% | ||
| Q2 24 | -0.5% | 19.6% | ||
| Q1 24 | -0.5% | 22.3% |
| Q4 25 | $2.34 | $2.05 | ||
| Q3 25 | $7.76 | $1.87 | ||
| Q2 25 | $-2.95 | $1.68 | ||
| Q1 25 | $3.33 | $1.57 | ||
| Q4 24 | $11.56 | $1.29 | ||
| Q3 24 | $-1.72 | $1.15 | ||
| Q2 24 | $-0.07 | $1.00 | ||
| Q1 24 | $-0.08 | $1.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $106.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $942.7M |
| Total Assets | $918.5M | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $106.9M | ||
| Q3 25 | $166.0M | $111.7M | ||
| Q2 25 | $96.7M | $81.3M | ||
| Q1 25 | $84.7M | $119.3M | ||
| Q4 24 | $40.6M | $80.4M | ||
| Q3 24 | $46.9M | $86.5M | ||
| Q2 24 | $40.8M | $47.8M | ||
| Q1 24 | $30.0M | $61.4M |
| Q4 25 | $329.4M | $942.7M | ||
| Q3 25 | $317.2M | $878.1M | ||
| Q2 25 | $235.3M | $847.2M | ||
| Q1 25 | $176.9M | $790.4M | ||
| Q4 24 | $132.4M | $729.0M | ||
| Q3 24 | $60.4M | $703.3M | ||
| Q2 24 | $62.7M | $532.6M | ||
| Q1 24 | $63.0M | $501.7M |
| Q4 25 | $918.5M | $3.1B | ||
| Q3 25 | $964.5M | $2.9B | ||
| Q2 25 | $841.0M | $2.8B | ||
| Q1 25 | $761.9M | $2.4B | ||
| Q4 24 | $655.3M | $2.3B | ||
| Q3 24 | $438.5M | $2.3B | ||
| Q2 24 | $422.4M | $2.0B | ||
| Q1 24 | $404.3M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $409.1M |
| Free Cash FlowOCF − Capex | $69.0M | $409.0M |
| FCF MarginFCF / Revenue | 45.5% | 161.4% |
| Capex IntensityCapex / Revenue | 0.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $700.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $409.1M | ||
| Q3 25 | $99.5M | $83.6M | ||
| Q2 25 | $27.3M | $120.9M | ||
| Q1 25 | $51.0M | $87.2M | ||
| Q4 24 | $54.0K | $261.2M | ||
| Q3 24 | $6.8M | $100.3M | ||
| Q2 24 | $13.3M | $55.1M | ||
| Q1 24 | $3.1M | $33.1M |
| Q4 25 | $69.0M | $409.0M | ||
| Q3 25 | $99.2M | $83.6M | ||
| Q2 25 | $26.5M | $120.8M | ||
| Q1 25 | $50.9M | $87.1M | ||
| Q4 24 | $-341.0K | $260.9M | ||
| Q3 24 | $6.2M | $100.1M | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | 161.4% | ||
| Q3 25 | 37.0% | 34.2% | ||
| Q2 25 | 10.9% | 59.4% | ||
| Q1 25 | 24.0% | 49.9% | ||
| Q4 24 | -0.1% | 167.5% | ||
| Q3 24 | 7.8% | 67.4% | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.2% | 0.2% | ||
| Q3 24 | 0.8% | 0.1% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | 1.63× | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | 2.40× | 2.03× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PLMR
Segment breakdown not available.
